Results-Based Financing Impact Evaluation 2015
Health Facility Endline Survey
Cameroon, 2015
Get Microdata
Reference ID
CMR_2015_RBFIE-FEL_v01_M
Producer(s)
Damien de Walque
Created on
Jan 30, 2025
Last modified
Jan 30, 2025
Page views
20490
Downloads
14
[14.1623u] Quelle est la présentation de [Pyrazinamide (en mg)] ? (f1_14_1623u)
Data file: f1_principal.dta
Overview
Valid:
205
Invalid:
28
Minimum:
2
Maximum:
12
Type:
Discrete
Decimal:
0
Start:
6137
End:
6138
Width:
2
Range:
2 - 12
Format:
Numeric
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 1 | Tube | 0 |
0%
|
| 2 | Comprimé | 189 |
92.2%
|
| 3 | flacon/poche | 0 |
0%
|
| 4 | plaquette | 0 |
0%
|
| 5 | sachet | 0 |
0%
|
| 6 | kit | 0 |
0%
|
| 7 | boîte | 1 |
0.5%
|
| 8 | ampoule | 0 |
0%
|
| 9 | Paquet | 0 |
0%
|
| 10 | unité | 1 |
0.5%
|
| 11 | Injectable | 13 |
6.3%
|
| 12 | sirop | 1 |
0.5%
|
| 13 | capsule | 0 |
0%
|
| 14 | dose | 0 |
0%
|
| 15 | goutte | 0 |
0%
|
| Sysmiss | 28 |
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.